Dissolving heart stent trial pulled before it even started
NCT ID NCT05417893
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aimed to compare a new type of heart stent that slowly dissolves over time (MeRes100) with standard permanent metal stents in people with coronary artery disease. The trial was planned to include about 2,000 participants worldwide, but it was withdrawn before enrolling anyone. Because no patients were treated, we cannot draw any conclusions about the safety or effectiveness of this device.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
sirolimus-eluting bioresorbable vascular scaffold
What this could lead to
If successful, this could offer a temporary scaffold that dissolves over time, potentially reducing long-term complications compared to permanent metal stents.
What could go wrong
The trial was withdrawn before any patients were enrolled, so no data is available. Earlier studies were small, and bioresorbable scaffolds have had mixed results in the past.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Botulinum Toxin to Prevent Post-Surgery AFib (NCT04075981)
- Stellate Ganglion Block for Heart Surgery Recove NCT07676487
- Smoking Cessation via Phone for Heart Patients (NCT00449852)
- Drug-Eluting Stent Study for Coronary Artery Dis NCT01186133
- VentriCure vs ECMO for High-Risk PCI – NCT07675005
- CONCARD Study: Heart Care After Stent (NCT03810612)